Inflammatory Pathways in Diabetes : Biomarkers and Clinical Correlates /
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | eBook |
| Language: | English |
| Published: |
Cham :
Springer International Publishing : Imprint: Springer,
2015.
|
| Edition: | 1st ed. 2015. |
| Series: | Progress in Inflammation Research,
|
| Subjects: |
Table of Contents:
- Part 1. Introduction
- 1. Impact of inflammation and the innate immunity response in obesity mediated diabetes (lit review)
- Part 2. Impact of complement on diabetic disease
- 2. Complement and Complement Regulatory Proteins in Diabetes
- Part 3. Role of C terminal fragment of adiponectin receptor in inhibition of insulin degradation
- 3. Development of adiponectin receptor C terminal fragment bioassays
- 4. Protease inhibition and biological distribution of the C terminal fragment of adiponectin receptor
- 5. Cell & biological models for the C terminal fragment of adiponectin receptor
- 6. C-Terminal fragment of adiponectin receptor clinical correlations
- Part 4. Uristatin assay for prediction of renal and other clinical events
- 7. Uristatin immunoassay usage in glomerular nephritis assessment
- 8. Acute Response of Uristatin in Surgery
- 9. Cardiovascular and metabolic syndrome impact on uristatin
- 10. Uristatin anti-inflammatory cellular signaling
- Part 5. Summary
- 11. Overview of progress in new markers for diabetes inflammation (Literatue Review).